Management of NTRK fusion-positive NSCLC: oncology case focus (part 1)

13 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
This enduring, case-based webcast brings together experts in pathology, oncology, and patient advocacy to clarify best practices for identifying and managing NTRK fusion -positive non-small cell lung cancer (NSCLC).

Jointly provided by the Postgraduate Institute for Medicine and Springer Health+ IME, the session offers practical, multidisciplinary guidance for real world care. 

Key learning points:

Detect rare NTRK fusions using current diagnostic approaches

Optimize treatment with TRK inhibitors through evidence-based strategies

Support shared decision-making with effective patient engagement

Watch the full interactive version here: https://nsclc-biomarkers-ime.springermedicine.com/courses/ntrk-webinar-on-demand/

Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc and intended healthcare professionals only.
Categoria
Oncology
Commenta per primo questo video.

Prossimo